Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

DENV inhibits type I IFN production in infected cells by cleaving human STING.

Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, Maringer K, Bernal-Rubio D, Shabman RS, Simon V, Rodriguez-Madoz JR, Mulder LC, Barber GN, Fernandez-Sesma A.

PLoS Pathog. 2012;8(10):e1002934. doi: 10.1371/journal.ppat.1002934. Epub 2012 Oct 4.

2.

Endoplasmic Reticulum Protein SCAP Inhibits Dengue Virus NS2B3 Protease by Suppressing Its K27-Linked Polyubiquitylation.

Liu H, Zhang L, Sun J, Chen W, Li S, Wang Q, Yu H, Xia Z, Jin X, Wang C.

J Virol. 2017 Apr 13;91(9). pii: e02234-16. doi: 10.1128/JVI.02234-16. Print 2017 May 1.

PMID:
28228593
3.

Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex.

Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, Fernandez-Sesma A.

J Virol. 2010 Oct;84(19):9760-74. doi: 10.1128/JVI.01051-10. Epub 2010 Jul 21.

4.

Innate immunity evasion by Dengue virus.

Morrison J, Aguirre S, Fernandez-Sesma A.

Viruses. 2012 Mar;4(3):397-413. doi: 10.3390/v4030397. Epub 2012 Mar 15. Review.

5.

Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.

Züst R, Toh YX, Valdés I, Cerny D, Heinrich J, Hermida L, Marcos E, Guillén G, Kalinke U, Shi PY, Fink K.

J Virol. 2014 Jul;88(13):7276-85. doi: 10.1128/JVI.03827-13. Epub 2014 Apr 16.

6.

Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.

He Z, Zhu X, Wen W, Yuan J, Hu Y, Chen J, An S, Dong X, Lin C, Yu J, Wu J, Yang Y, Cai J, Li J, Li M.

J Virol. 2016 Jul 27;90(16):7219-30. doi: 10.1128/JVI.00221-16. Print 2016 Aug 15.

7.

Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling.

Morrison J, Laurent-Rolle M, Maestre AM, Rajsbaum R, Pisanelli G, Simon V, Mulder LC, Fernandez-Sesma A, García-Sastre A.

PLoS Pathog. 2013 Mar;9(3):e1003265. doi: 10.1371/journal.ppat.1003265. Epub 2013 Mar 28.

8.

Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production.

Masrinoul P, Omokoko MD, Pambudi S, Ikuta K, Kurosu T.

Viral Immunol. 2013 Aug;26(4):250-8. doi: 10.1089/vim.2012.0102.

PMID:
23941673
9.

Dengue virus inhibits the production of type I interferon in primary human dendritic cells.

Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A.

J Virol. 2010 May;84(9):4845-50. doi: 10.1128/JVI.02514-09. Epub 2010 Feb 17. Erratum in: J Virol. 2011 Mar;85(6):3042.

10.

Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication.

Hishiki T, Han Q, Arimoto K, Shimotohno K, Igarashi T, Vasudevan SG, Suzuki Y, Yamamoto N.

Biochem Biophys Res Commun. 2014 May 23;448(1):95-100. doi: 10.1016/j.bbrc.2014.04.081. Epub 2014 Apr 21.

PMID:
24769207
11.

Innate immunity to dengue virus infection and subversion of antiviral responses.

Green AM, Beatty PR, Hadjilaou A, Harris E.

J Mol Biol. 2014 Mar 20;426(6):1148-60. doi: 10.1016/j.jmb.2013.11.023. Epub 2013 Dec 3. Review.

12.

Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response.

Silveira GF, Strottmann DM, de Borba L, Mansur DS, Zanchin NI, Bordignon J, dos Santos CN.

Clin Exp Immunol. 2016 Jan;183(1):114-28. doi: 10.1111/cei.12701. Epub 2015 Oct 18.

13.

Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses.

Surasombatpattana P, Hamel R, Patramool S, Luplertlop N, Thomas F, Desprès P, Briant L, Yssel H, Missé D.

Infect Genet Evol. 2011 Oct;11(7):1664-73. doi: 10.1016/j.meegid.2011.06.009. Epub 2011 Jun 21.

PMID:
21722754
14.

Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.

Anghelina D, Lam E, Falck-Pedersen E.

J Virol. 2016 Jun 10;90(13):5915-27. doi: 10.1128/JVI.00500-16. Print 2016 Jul 1.

15.

The polypyrimidine tract-binding protein is required for efficient dengue virus propagation and associates with the viral replication machinery.

Anwar A, Leong KM, Ng ML, Chu JJ, Garcia-Blanco MA.

J Biol Chem. 2009 Jun 19;284(25):17021-9. doi: 10.1074/jbc.M109.006239. Epub 2009 Apr 20.

16.

The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.

Cotter CR, Kim WK, Nguyen ML, Yount JS, López CB, Blaho JA, Moran TM.

J Virol. 2011 Dec;85(23):12662-72. doi: 10.1128/JVI.05557-11. Epub 2011 Sep 21.

17.

IRAV (FLJ11286), an Interferon-Stimulated Gene with Antiviral Activity against Dengue Virus, Interacts with MOV10.

Balinsky CA, Schmeisser H, Wells AI, Ganesan S, Jin T, Singh K, Zoon KC.

J Virol. 2017 Feb 14;91(5). pii: e01606-16. doi: 10.1128/JVI.01606-16. Print 2017 Mar 1.

18.

The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus.

Lim DS, Yawata N, Selva KJ, Li N, Tsai CY, Yeong LH, Liong KH, Ooi EE, Chong MK, Ng ML, Leo YS, Yawata M, Wong SB.

J Immunol. 2014 Nov 15;193(10):5065-75. doi: 10.4049/jimmunol.1302240. Epub 2014 Oct 15.

19.

MicroRNA-like viral small RNA from Dengue virus 2 autoregulates its replication in mosquito cells.

Hussain M, Asgari S.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2746-51. doi: 10.1073/pnas.1320123111. Epub 2014 Feb 3.

20.

Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-κB activation to downregulate cytokine production.

Chang TH, Chen SR, Yu CY, Lin YS, Chen YS, Kubota T, Matsuoka M, Lin YL.

PLoS One. 2012;7(8):e41635. doi: 10.1371/journal.pone.0041635. Epub 2012 Aug 22.

Supplemental Content

Support Center